We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Emergency Alerts Test on Sunday 7 September, 3pm
This plan sets out how HM Treasury plans to improve the use of British Sign Language (BSL) in its communications in the next 5 years.
BSL version https://www.youtube.com/watch?v=TrVmDClUEaA Introduction In…
This plan sets out how the Wales Office plans to improve the use of British Sign Language (BSL) in its communications in the next 5 years.
1. BSL version https://www.youtube.com/watch?v=nlxe4Gb7Vw0 2. Statement of…
Call for evidence to support ACMD's review of the misuse and harms of gabapentin and pregabalin.
About this call for evidence The Advisory Council on the Misuse of Drugs…
This document details the Government's response to the recommendations made by the Infected Blood Inquiry
DHSC and NHS England’s ongoing work and future plans to improve shortage management and strengthen medicines supply chain resilience.
The MHRA invites health institutions in Great Britain to share their experience of the health institution exemption (sometimes referred to as an in-house manufacturing exemption).
This call for evidence seeks views on how the current system operates in relation to patient access to medicines through private (non-NHS) routes.
The MHRA is consulting with UK stakeholders to gather feedback and comments on a revised international guideline, M4Q(R2).
Impact assessment and equality impact assessment of human papillomavirus (HPV) self-sampling in the NHS Cervical Screening Programme.
We are seeking your views on what procedures should be in scope of the licensing scheme for non-surgical cosmetic procedures in England.
This consultation seeks views on extending medicines responsibilities for paramedics, physiotherapists, operating department practitioners and diagnostic radiographers.
The Advisory Council on the Misuse of Drugs (ACMD) is calling for evidence on ketamine use, harms and interventions.
An update on progress the government has made to go beyond implementing the Lord O'Shaughnessy review of commercial clinical trials and how it is going further and faster to transform the UK clinical research system.
Impact assessment and equality impact assessment of risk stratification in the NHS Cervical Screening Programme in England.
This page details the Government's response to the Infected Blood Inquiry’s Additional Report on 9 July 2025.
Sets out the government’s 10 Year Health Plan for England.
Details of the meetings held by the Interministerial Group (IMG) for Health and Social Care.
The MHRA is consulting with UK stakeholders to gather feedback and comments on ICH E20, a new international guideline.
Equality impact assessment for targeted screening for lung cancer.
We are seeking views on proposals to change the way government allocates funding for the Disabled Facilities Grant (DFG) to local authorities in England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).